Systematic review / meta-analysis / 2017
Oral potassium supplementation modestly reduced blood pressure in adults with primary hypertension
A meta-analysis evaluated 23 randomized placebo-controlled trials encompassing 1,213 individuals with primary hypertension treated for at least 4 weeks. Potassium supplementation reduced systolic blood pressure by 4.25 mmHg (95% CI: -5.96 to -2.53) and diastolic blood pressure by 2.53 mmHg (95% CI: -4.05 to -1.02). The authors reported no significant adverse events associated with the intervention.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 1,213 adults with primary hypertension across 23 randomized trials
- What was measured
- Systolic and diastolic blood pressure
THE PAPER
Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
Poorolajal J, Zeraati F, Soltanian AR, Sheikh V, Hooshmand E, Maleki A. PLoS One, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.